The Biotech Investor's Bible

Overview

The complete guide to investing in the biotech industry

"Clear, never condescending, and with abundant references to biotech firms and their work in progress, The Biotech Investor's Bible is a book that had to be written. Essential for the investor, fascinating even for armchair students of the industry, it's a valuable reference, a guide to what is coming, and an irresistible read . . . it will be a definitive reference in the field."?Andrew Allentuck, globetechnology.com

"The Biotech Investor's Bible outlines ...

See more details below
Other sellers (Hardcover)
  • All (15) from $2.45   
  • New (10) from $10.72   
  • Used (5) from $2.45   
Sending request ...

Overview

The complete guide to investing in the biotech industry

"Clear, never condescending, and with abundant references to biotech firms and their work in progress, The Biotech Investor's Bible is a book that had to be written. Essential for the investor, fascinating even for armchair students of the industry, it's a valuable reference, a guide to what is coming, and an irresistible read . . . it will be a definitive reference in the field."—Andrew Allentuck, globetechnology.com

"The Biotech Investor's Bible outlines sensibly and with balance the opportunities and challenges of an industry that will change our lives. A must read guide for the individual investor."—William A. Haseltine, Ph.D., Chairman, CEO, and Founder, Human Genome Sciences, Inc., Editor-in-chief, E-Biomed: The Journal of Regenerative Medicine

Investors with a practical understanding of biotechnology share a remarkable opportunity: the chance to invest in an industry on the threshold of tremendous growth. With the long-term potential to cure most major diseases and to revolutionize industries as diverse as pharmaceuticals and forestry, petrochemicals and agriculture, the possibilities for biotech—and its investors—are limitless.

The Biotech Investor's Bible provides you with the strategies and proven techniques to reduce risk and increase returns, including:
* The steps you must know in order to assess the biotech market ?
* A comprehensive look at 185 major biotech companies ?
* Guidelines to follow when planning your biotech portfolio ?
* An overview of the latest biotech therapies and breakthroughs ?
* Tips on how to find sound and promising companies in the sector ?
* An easy-to-understand introduction to the science and technology in the field ?

Read More Show Less

Editorial Reviews

Booknews
An investment consultant, formerly a journalist who reported on the emergence of recombinant DNA technology, discusses the maturing biotech sector from new investment strategy and scientific/ technological perspectives. Appendices include a breakdown of 185 major biotech companies by market cap and tier, resources, and a glossary of biotech terms. Annotation c. Book News, Inc., Portland, OR (booknews.com)
Read More Show Less

Product Details

  • ISBN-13: 9780471412793
  • Publisher: Wiley
  • Publication date: 6/13/2001
  • Edition number: 1
  • Pages: 336
  • Sales rank: 1,116,758
  • Product dimensions: 9.00 (w) x 6.00 (h) x 0.88 (d)

Meet the Author

GEORGE WOLFF is an award-winning journalist and, currently, a private business consultant to several firms in the investment industry. He has assessed and reported on more than 200 biotechnology companies for his clientele, issuing a number of valuable white papers charting the emergence of biotechnology. Previously, as a journalist, Wolff worked internationally covering the onset of the AIDS epidemic, the emergence of recombinant DNA technology, and the extraordinary stock market events of the previous twenty years. Wolff can be contacted through his web site, BioWolff.com.

Read More Show Less

Table of Contents

PART I.

Introduction.

On the Threshold.

Assessing the Biotech Market.

The Keys to Biotech Investing.

Going Over Biotech Books.

The Four Tiers of Biotech Companies.

Biotechnology and Portfolio Planning.

Decision Making.

The Sector in Perspective.

The Biotech Investor's Checklist.

PART II.

The Science Behind the Industry.

The Language of Genes.

The Realms of Biotechnology (or Who's Doing What).

The Pick and Shovels of Biotechnology.

The New Biotech Therapies.

Special Sectors.

Appendix A: A Breakdown of 185 Major Biotech Companies.

Appendix B: Resources.

Appendix C: A Glossary of Terms.

Notes.

Index.

Read More Show Less

Customer Reviews

Be the first to write a review
( 0 )
Rating Distribution

5 Star

(0)

4 Star

(0)

3 Star

(0)

2 Star

(0)

1 Star

(0)

Your Rating:

Your Name: Create a Pen Name or

Barnes & Noble.com Review Rules

Our reader reviews allow you to share your comments on titles you liked, or didn't, with others. By submitting an online review, you are representing to Barnes & Noble.com that all information contained in your review is original and accurate in all respects, and that the submission of such content by you and the posting of such content by Barnes & Noble.com does not and will not violate the rights of any third party. Please follow the rules below to help ensure that your review can be posted.

Reviews by Our Customers Under the Age of 13

We highly value and respect everyone's opinion concerning the titles we offer. However, we cannot allow persons under the age of 13 to have accounts at BN.com or to post customer reviews. Please see our Terms of Use for more details.

What to exclude from your review:

Please do not write about reviews, commentary, or information posted on the product page. If you see any errors in the information on the product page, please send us an email.

Reviews should not contain any of the following:

  • - HTML tags, profanity, obscenities, vulgarities, or comments that defame anyone
  • - Time-sensitive information such as tour dates, signings, lectures, etc.
  • - Single-word reviews. Other people will read your review to discover why you liked or didn't like the title. Be descriptive.
  • - Comments focusing on the author or that may ruin the ending for others
  • - Phone numbers, addresses, URLs
  • - Pricing and availability information or alternative ordering information
  • - Advertisements or commercial solicitation

Reminder:

  • - By submitting a review, you grant to Barnes & Noble.com and its sublicensees the royalty-free, perpetual, irrevocable right and license to use the review in accordance with the Barnes & Noble.com Terms of Use.
  • - Barnes & Noble.com reserves the right not to post any review -- particularly those that do not follow the terms and conditions of these Rules. Barnes & Noble.com also reserves the right to remove any review at any time without notice.
  • - See Terms of Use for other conditions and disclaimers.
Search for Products You'd Like to Recommend

Recommend other products that relate to your review. Just search for them below and share!

Create a Pen Name

Your Pen Name is your unique identity on BN.com. It will appear on the reviews you write and other website activities. Your Pen Name cannot be edited, changed or deleted once submitted.

 
Your Pen Name can be any combination of alphanumeric characters (plus - and _), and must be at least two characters long.

Continue Anonymously
Sort by: Showing all of 5 Customer Reviews
  • Anonymous

    Posted December 28, 2011

    Highly recommend this book!

    This is a must read for anyone who wants to understand the world of BioTech Investing!

    1 out of 1 people found this review helpful.

    Was this review helpful? Yes  No   Report this review
  • Anonymous

    Posted June 13, 2001

    The best biotech investor's guide

    I have been investing in biotech for several years. This book is one of several that I have read and it has really helped me to make wise choices. A great book!

    1 out of 1 people found this review helpful.

    Was this review helpful? Yes  No   Report this review
  • Anonymous

    Posted June 10, 2001

    Great!

    Great Information!

    1 out of 1 people found this review helpful.

    Was this review helpful? Yes  No   Report this review
  • Anonymous

    Posted June 13, 2001

    Biotech - What every investor should know

    I highly recommend this important book! You would have to be living under a rock to have not heard about the great advances made recently in genetics and biotechnology. The potential for a cure to cancer, the ability to fix previously incurable diseases, and many other medical advancements are becoming closer to reality because of biotechnology. But where could an investor go to educate himself on the many issues facing this industry? Nowhere. Until now. Investors who can sort through the myriad of scientific, corporate and government issues relating to this industry will be have a great advantage over the rest of us. George Wolff's highly readable primer gives its readers this advantage. As an investment advisor, I know the great potential of biotech. All you need to do is look at the multi-hundred billion dollar market capitalization of the Mercks and Pfizers to know that success in drug development holds the key to untold riches. But which companies will get there? How do you as an investor approach this very complex field? George Wolff's Biotech Investor's Bible thoughtfully lays out the key issues an investor must be familiar with. Product pipelines, alliances with major drug companies, strategies companies use to speed up FDA trials, valuation techniques, and a myriad of other important issues are thoroughly explained by Wolff in plain English. A huge run-up in biotech stock prices in early 2000 was sparked by the expectation that the human genome would be mapped. The bubble burst in March 2000, leaving many of the hottest stocks broken and battered. The theoretical excitement however, has given way now to a market that is focused on the companies that have an aggregate of several hundred drugs in various stages of FDA trials. Many of these stocks have recovered and in some cases gone on to new highs. Wolff provides not only the overview of the industry you need, but also the means to determine which individual companies show the greatest promise. Without this book and its comprehensive explanation of biotech investing, I would never attempt to participate in this market. But you should ask yourself: can you afford not to? With the tech sector in a shambles, with the stock market stagnating in general, what will bring on the next high-growth trend? A strong case for biotech is made by the author. The fast pace of research, the growing base of scientific knowledge in the field, and the several current winners like Amgen which sports a $65 billion market capitalization, all clearly point to the future development of many new, effective treatments which will be brought forth at an ever-increasing rate for decades to come. I for one plan to stay informed and involved with my investment dollars. You truly would omit this book from your reading list at your own financial peril.

    1 out of 1 people found this review helpful.

    Was this review helpful? Yes  No   Report this review
  • Anonymous

    Posted June 13, 2001

    Wish I'd been able to read this a year ago

    Whether you are interested in investing in the medical stocks of tomorrow or just want to feel less inadequate the next time you read about this controversial and yet awe-inspiring field, you will be glad you read this extremely well written and well researched book. It helps you to differentiate among the biotech companies and understand how to evaluate their present worth and future potential. In addition, it manages to simplify and explain much of the science behind the headlines. Excellent information on the drug approval process, how to critically evaluate clinical trial results and where to go to do detailed research on the companies in this sector. I don't know how anyone could be foolhardy enough to invest in the biotech field before intensive research -- and The Biotech Bible is the perfect place to start. I thoroughly enjoyed this 'college course' on Biotech investing.

    Was this review helpful? Yes  No   Report this review
Sort by: Showing all of 5 Customer Reviews

If you find inappropriate content, please report it to Barnes & Noble
Why is this product inappropriate?
Comments (optional)